Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses
2013 · Cancer Gene Therapy · 16 citations
https://doi.org/10.1038/cgt.2013.60